SCHEMBL8966095

SCHEMBL8966095

COc1cc(CCc2ccc(=O)[nH]n2)cc(OC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB4A P04350 3/20 0.49
▸ TUBB P07437 3/20 0.49
▸ TUBA3C P0DPH7 3/20 0.49
▸ TUBA1B P68363 3/20 0.49
▸ TUBA4A P68366 3/20 0.49
▸ TUBB4B P68371 3/20 0.49
▸ TUBB3 Q13509 3/20 0.49
▸ TUBB2A Q13885 3/20 0.49
▸ TUBB8 Q3ZCM7 3/20 0.49
▸ TUBA3E Q6PEY2 3/20 0.49
▸ TUBA1A Q71U36 3/20 0.49
▸ TUBA1C Q9BQE3 3/20 0.49
▸ TUBB6 Q9BUF5 3/20 0.49
▸ TUBB2B Q9BVA1 3/20 0.49
▸ TUBB1 Q9H4B7 3/20 0.49
▸ CYP19A1 P11511 1/20 0.48
▸ DHFR P00374 1/20 0.47
▸ HTR2A P28223 1/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ HTR2B P41595 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4464142 0.74 HTR2A (0.75) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL11005422 0.73 PDE4A (0.72) SMN1; SMN2POLBPDE4APDE4BPDE4C
SCHEMBL8965596 0.71 CYP19A1 (0.58) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL8965956 0.71 TUBB4A (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL8481242 0.69 MAPT (0.46) SMN1; SMN2POLBKDM4EALDH1A1GLA
SCHEMBL8966189 0.69 LMNA (0.63) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL10761840 0.69 LMNA (0.63) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7276901 0.68 AR (0.55) HTR2CPDE4APDE4BPDE4CPDE4D
SCHEMBL29689431 0.68 TUBB4A (0.74) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL21530612 0.68 TUBB4A (0.70) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538970-A Treatment of cancer with imidazo-1,2-pyridazin compounds GLAXO WELLCOME INC. (US) 1996-07-23 — — US disclosed
US-5447956-A Anticarcinogenic agents BURROUGHS WELLCOME CO. (US) 1995-09-05 — — US disclosed
US-5380759-A Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemia BURROUGHS WELLCOME CO. (US) 1995-01-10 — — US disclosed
US-5371219-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1994-12-06 — — US disclosed
EP-0305093-B1 Imidazo(1,2-b)pyridazine derivatives WELLCOME FOUND (GB) 1994-04-06 — — EP disclosed
US-5091531-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1992-02-25 — — US disclosed
EP-0305093-A1 Imidazo(1,2-b)pyridazine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1989-03-01 — — EP disclosed
Send feedback